In a report released today, Peter Lawson from Barclays maintained a Hold rating on Exelixis (EXEL – Research Report), with a price target ...
Exelixis (EXEL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stephen Willey ...
S ean Korbitz was a 20-year-old college student when he first started experiencing symptoms of von Hippel-Lindau syndrome, ...